Advanced Biomed is trading 6.1% up at $17.80 in pre-market, extending a sharp multi-day rally after the company canceled a planned securities offering that had worried investors about dilution.

  • The stock previously surged 73.02% on July 22 and 36.98% on July 23 following the decision to scrap the capital raise.
  • Pre-market strength suggests continued positive reaction to the improved outlook for the company’s funding plans and capital structure.